Some weeks back I blogged about the seemingly erroneous Audited Financial Statements released by Presco on the website of the NSE. They have now updated the results correcting some of the glaring errors in the financials. Though, I still have some unanswered questions, particulary with the cash flow statements as well as their valuation metrics for revaluation of biological assets and the tax implications. All the same, Presco looks like a fundamentally sound company and still worthy of my investment.
Presco 2012 Audited Accounts was updated on the website of the NSE
